Natural Capsules Ltd

Natural Capsules Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Natural Capsules Ltd

₹ 156 1.57%
12 Jun - close price
naturalcapsules.com BSE: 524654 NSE: NATCAPSUQ
About

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Key Points

Business Overview:[1][2][3]
NCL is a WHO-GMP certified and ISO 9001, ISO 140001 compliance manufacturer of printed and unprinted hard two-piece Gelatin and Cellulose (HPMC : non-animal alternative) capsules for pharmaceutical and dietary supplement industries in various sizes of 00, 0el, 0, 1, 2, 3 & 4. Apart from this, NCL has forayed into API manufacturing with complex high-end patented technology developed in-house, under its subsidiary company Natural Biogenex Private Limited.

Website BSE NSE
  • Market Cap ₹ 162 Cr.
  • Current Price ₹ 156
  • High / Low ₹ 296 / 136
  • Stock P/E 14.4
  • Book Value ₹ 173
  • Dividend Yield 0.00 %
  • ROCE 9.02 %
  • ROE 6.48 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.90 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.72% over last 3 years.
  • Contingent liabilities of Rs.70.8 Cr.
  • Earnings include an other income of Rs.7.65 Cr.
  • Promoter holding has decreased over last 3 years: -5.52%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
38.12 37.70 37.52 38.38 40.20 39.14 41.03 43.41 44.36 44.24 44.58 34.15 50.80
31.23 31.64 32.28 33.44 35.70 34.41 36.09 38.82 39.32 39.10 39.14 32.26 41.95
Operating Profit 6.89 6.06 5.24 4.94 4.50 4.73 4.94 4.59 5.04 5.14 5.44 1.89 8.85
OPM % 18.07% 16.07% 13.97% 12.87% 11.19% 12.08% 12.04% 10.57% 11.36% 11.62% 12.20% 5.53% 17.42%
0.81 0.58 0.61 0.71 1.26 0.76 0.77 1.15 1.55 1.69 1.73 2.11 2.13
Interest 1.27 1.21 1.15 1.20 1.38 1.46 1.54 1.39 1.52 1.36 1.45 1.45 1.49
Depreciation 1.86 2.11 2.16 2.16 2.14 2.09 2.16 2.14 1.94 1.99 2.02 2.09 2.06
Profit before tax 4.57 3.32 2.54 2.29 2.24 1.94 2.01 2.21 3.13 3.48 3.70 0.46 7.43
Tax % 26.26% 25.90% 22.44% 25.76% 24.55% 24.74% 54.23% 23.08% 16.29% 27.30% 24.05% 19.57% 25.71%
3.37 2.46 1.97 1.70 1.69 1.46 0.92 1.70 2.63 2.52 2.81 0.36 5.52
EPS in Rs 3.66 2.65 2.12 1.82 1.81 1.56 0.90 1.64 2.54 2.44 2.72 0.35 5.31
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
67 62 54 55 60 62 80 135 171 153 168 174
56 52 49 49 55 56 68 109 135 132 148 152
Operating Profit 12 10 5 6 5 5 11 26 36 21 19 21
OPM % 17% 16% 10% 10% 8% 9% 14% 19% 21% 14% 12% 12%
1 1 0 1 1 1 3 1 1 3 4 8
Interest 1 1 1 0 1 1 1 2 4 5 6 6
Depreciation 4 4 4 4 3 4 4 5 7 9 8 8
Profit before tax 8 6 0 2 2 1 9 19 26 10 9 15
Tax % 25% 28% -103% 34% 7% 38% 24% 28% 25% 25% 28% 26%
6 4 1 1 2 1 7 14 19 8 7 11
EPS in Rs 7.15 4.99 0.68 1.19 2.06 0.92 7.47 15.00 20.83 8.38 6.49 10.79
Dividend Payout % 14% 20% 99% 56% 32% 43% 9% 5% 5% 0% 0% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 17%
3 Years: 1%
TTM: 4%
Compounded Profit Growth
10 Years: 10%
5 Years: 16%
3 Years: -16%
TTM: 67%
Stock Price CAGR
10 Years: 7%
5 Years: 3%
3 Years: -24%
1 Year: -32%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 6%
Last Year: 6%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5 6 6 6 6 6 6 7 9 9 10 10
Reserves 42 50 48 48 49 49 56 76 115 123 156 169
5 6 3 0 5 6 10 33 49 62 56 59
11 16 14 19 14 14 26 28 38 37 45 57
Total Liabilities 63 77 71 73 75 76 98 144 211 231 268 296
29 30 26 22 24 24 35 63 93 91 88 88
CWIP 2 0 0 1 2 2 3 1 0 2 0 2
Investments 0 5 5 5 5 6 0 0 20 23 23 23
32 42 40 45 43 45 60 80 98 116 157 184
Total Assets 63 77 71 73 75 76 98 144 211 231 268 296

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
5 3 2 5 2 7 6 5 20 5 18 36
-4 -8 -0 -1 -7 -6 -9 -30 -55 -11 -34 -34
-1 4 -2 -4 4 -1 3 27 34 7 15 -3
Net Cash Flow -0 0 0 0 -1 0 -0 1 -1 2 -2 -0
Free Cash Flow 2 1 2 4 -5 2 -11 -25 -16 -3 16 26
CFO/OP 60% 51% 41% 97% 57% 144% 72% 38% 72% 35% 103% 186%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 125 167 191 208 197 180 123 71 111 128 133 129
Inventory Days 66 147 119 149 87 89 82 34 43 83 92 85
Days Payable 74 148 159 185 114 91 157 97 127 140 155 177
Cash Conversion Cycle 117 166 151 172 170 179 48 7 28 70 70 37
Working Capital Days 87 123 155 186 136 121 114 32 28 30 40 -3
ROCE % 17% 12% 3% 4% 5% 4% 11% 23% 20% 8% 7% 9%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Annual Production Capacity (Capsules)
Billion Capsules

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization (Capsules)
%
Number of Employees
Count
Production Volume (Capsules)
Billion Capsules
Sales Volume (Capsules)
Billion Capsules
Number of Customers
Count
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
56.57% 56.57% 56.57% 56.57% 56.57% 51.59% 51.13% 51.21% 51.26% 51.26% 51.26% 51.04%
1.31% 1.31% 1.31% 1.31% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
42.13% 42.13% 42.13% 42.13% 43.25% 48.39% 48.86% 48.80% 48.75% 48.73% 48.74% 48.96%
No. of Shareholders 10,80511,67511,39910,95410,5149,8629,6619,4259,3119,5739,0758,850

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls